Attached is herewith Annual Secretarial Compliance Report for the Financial year ended March 31, 2025.
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025 to NSE and BSE on May 15, 2025. The report was prepared by V Suresh Associates, Practising Company Secretaries, as mandated under Regulation 24A of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The Practising Company Secretary reviewed the company's compliance across 13 specific areas including SEBI regulations, insider trading norms, related party transactions, director disqualifications, subsidiary disclosures, and corporate governance policies. The report is completely clean with NIL observations or deviations recorded, and all 13 compliance checkpoints show a 'Yes' status. No actions were taken by SEBI or the stock exchanges against the company, its promoters, directors, or subsidiaries during the review period.
This is a routine annual compliance filing confirming a clean governance record with no regulatory penalties or non-compliance issues. No material impact on stock price is expected — it simply reinforces Thyrocare's standing as a compliant listed entity.